FP.37 CDP-ribitol prodrug treatment ameliorates ISPD-deficient muscular dystrophy mouse model

Autor:	H. Tokuoka, R. Imae, H. Nakashima, H. Manya, C. Masuda, S. Hoshino, K. Kobayashi, D. Lefeber, R. Matsumoto, T. Okada, T. Endo, M. Kanagawa, T. Toda
Rok vydání:	2022
Předmět:	Neurology Pediatrics Perinatology and Child Health Neurology (clinical) Genetics (clinical)
Zdroj:	Neuromuscular Disorders. 32:S120
ISSN:	0960-8966
DOI:	10.1016/j.nmd.2022.07.323
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::685732cc866f4330d68e79dd63ab9b93 https://doi.org/10.1016/j.nmd.2022.07.323 Zobrazit plný text záznamu Full Text from ScienceDirect